Literature DB >> 1666278

Human papillomavirus infection in vulvar lesions of lichen sclerosus et atrophicus.

P Kiene1, K Milde-Langosch, T Löning.   

Abstract

Human papillomaviruses (HPV) types 6, 11, 16 and 18 infections were investigated in 18 vulvar lesions of lichen sclerosus et atrophicus (LSA) using in situ DNA hybridization and polymerase chain reaction (PCR) on formalin-fixed paraffin-embedded specimens. Four out of 18 specimens were found to be infected with HPV type 16 using the PCR technique. Interestingly, three of these four patients were in a premenopausal state. This difference proved to be the only distinguishing feature in a comparison of HPV type 16-infected patients with non-infected patients. In situ hybridization revealed no positive result in any case and PCR demonstrated no HPV-DNA type 6, 11 or 18. Patients with HPV type 16-infected lesions may be regarded as at risk of developing vulvar cancer. Therefore, long-term follow-up of this subgroup is particularly important.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1666278     DOI: 10.1007/bf00371780

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  22 in total

1.  Lichen sclerosus, invasive squamous cell carcinoma, and human papillomavirus.

Authors:  S M Neill; M Lessana-Leibowitch; M Pelisse; M Moyal-Barracco
Journal:  Am J Obstet Gynecol       Date:  1990-06       Impact factor: 8.661

Review 2.  Heterogeneity of the human papillomavirus group.

Authors:  E M de Villiers
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

3.  Lichen sclerosus et atrophicus.

Authors:  H J Wallace
Journal:  Trans St Johns Hosp Dermatol Soc       Date:  1971

4.  Lichen sclerosus et atrophicus and autoimmunity--a study of 350 women.

Authors:  R H Meyrick Thomas; C M Ridley; D H McGibbon; M M Black
Journal:  Br J Dermatol       Date:  1988-01       Impact factor: 9.302

5.  Human papillomavirus-associated early vulvar neoplasia investigated by in situ hybridization.

Authors:  J Gupta; S Pilotti; K V Shah; G De Palo; F Rilke
Journal:  Am J Surg Pathol       Date:  1987-06       Impact factor: 6.394

6.  Sexually transmitted papillomaviral infections. I. The anatomic distribution and pathologic grade of neoplastic lesions associated with different viral types.

Authors:  R Reid; M Greenberg; A B Jenson; M Husain; J Willett; Y Daoud; G Temple; C R Stanhope; A I Sherman; G D Phibbs
Journal:  Am J Obstet Gynecol       Date:  1987-01       Impact factor: 8.661

7.  Polymerase chain reaction for fast, nonradioactive detection of high- and low-risk papillomavirus types in routine cervical specimens and in biopsies.

Authors:  P B Dallas; J L Flanagan; B N Nightingale; B J Morris
Journal:  J Med Virol       Date:  1989-02       Impact factor: 2.327

8.  Human papillomavirus infections in women with and without abnormal cervical cytology.

Authors:  E M de Villiers; D Wagner; A Schneider; H Wesch; H Miklaw; J Wahrendorf; U Papendick; H zur Hausen
Journal:  Lancet       Date:  1987-09-26       Impact factor: 79.321

9.  Detection of human papillomavirus deoxyribonucleic acid from vulvar dystrophies and vulvar intraepithelial neoplastic lesions.

Authors:  M Karram; B Tabor; D Smotkin; F Wettstein; N Bhatia; J Micha
Journal:  Am J Obstet Gynecol       Date:  1988-07       Impact factor: 8.661

10.  Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction.

Authors:  D K Shibata; N Arnheim; W J Martin
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

View more
  2 in total

1.  Lichen sclerosus et atrophicus and sexual abuse.

Authors:  S A Warrington; C de San Lazaro
Journal:  Arch Dis Child       Date:  1996-12       Impact factor: 3.791

Review 2.  Uncommon oral manifestation of lichen sclerosus: critical analysis of cases reported from 1957 to 2016.

Authors:  S Tomo; I-S Santos; S-A de Queiroz; D-G Bernabé; L-E Simonato; G-I Miyahara
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.